Inventor
Eunsil SUNG
Inventor
KR
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes30%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
C07KPeptides30%
G01NInvestigating or analysing materials by determining their chemical or physical properties11%
PatentTitleYear
12,577,313Anti-claudin 18.2 and anti-4-1BB bispecific antibodies and uses thereof202612,195,538Anti-PD-L1/anti-4-1BB bispecific antibodies and uses thereof202512,168,690Anti-EGFR/anti-4-1BB bispecific antibody202412,122,830Anti-ROR1 antibody and use thereof202412,071,483Bispecific antibody to alpha-synuclein/insulin-like growth factor 1 receptor and use thereof202412,049,493Anti-alpha-synuclein antibodies and uses thereof202411,891,445Anti-B7-H3 antibody and use thereof202411,261,259Anti-claudin 18.2 and anti-4-1BB bispecific antibodies and uses thereof2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to ABL BIO INC (8)· patent assignee history
2022–2026Patents assigned to I MAB BIOPHARMA US LTD (3)· patent assignee history
2022–2026Based in KR· patent location history
2024Patents assigned to YUHAN CORP (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ABL BIO INC | 8 | 2022–2026 |
| I MAB BIOPHARMA US LTD | 3 | 2022–2026 |
| YUHAN CORP | 1 | 2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| KR | 8 | 2022–2026 |